Cytek Biosciences Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

3.71

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

3.94

6.34%

Pre-market: May 02, 2025, 04:48 AM EDT

Cytek Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	98.72M	167.3M	296.6M	364.62M	165.23M	30.12M
Short-Term Investments	179.15M	95.11M	44.55M	n/a	n/a	n/a
Long-Term Investments	n/a	1.6M	1.6M	n/a	n/a	250K
Other Long-Term Assets	4.76M	1.78M	1.36M	1.67M	1.09M	-63K
Receivables	60.59M	56.12M	48.86M	29.76M	18.1M	17.75M
Inventory	43.89M	60.88M	48.15M	32.17M	23.02M	18.43M
Other Current Assets	1.97M	2.56M	10.79M	708K	1.33M	419K
Total Current Assets	396.45M	392.06M	454.02M	432.05M	208.62M	67.77M
Property-Plant & Equipment	28.13M	29.26M	27.57M	5.85M	2.14M	1.04M
Goodwill & Intangibles	36.79M	39.27M	14.47M	14.88M	750K	739K
Total Long-Term Assets	103.05M	102.4M	65.46M	31.65M	11.36M	2.6M
Total Assets	499.5M	494.46M	519.48M	463.7M	219.98M	70.36M
Account Payables	5.53M	3.03M	4.8M	3.03M	2.94M	2.34M
Deferred Revenue	25.49M	22.7M	12.99M	7.08M	4.29M	3.47M
Short-Term Debt	n/a	565K	9.69M	n/a	2.77M	n/a
Other Current Liabilities	18.32M	21.2M	21.1M	11.47M	10.5M	12.43M
Total Current Liabilities	67.66M	56.23M	49.04M	32.16M	26.54M	21.04M
Long-Term Debt	1.05M	1.65M	2.27M	n/a	n/a	n/a
Other Long-Term Liabilities	18.95M	18.91M	17.18M	14.95M	206.01M	89.24M
Total Long-Term Liabilities	36.1M	45.17M	44.89M	24.74M	209.47M	91.02M
Total Liabilities	103.76M	101.39M	93.93M	56.9M	236.01M	112.06M
Total Debt	17.02M	14.14M	18.09M	n/a	2.77M	n/a
Common Stock	129K	131K	135K	126K	23K	21K
Retained Earnings	-35.2M	-29.18M	-17.03M	-18.19M	-22.61M	-42.02M
Comprehensive Income	16K	-1.27M	-697K	897K	65K	-147K
Shareholders Equity	395.74M	393.06M	425.3M	406.46M	-16.03M	-41.7M
Total Investments	179.15M	96.71M	44.55M	n/a	n/a	250K